Seòmar agus comataidhean

Information on the incidenceof osteoporosis in Scotland is not available centrally. Information for Scottish Parliamentary constituencies and for Scottish parliamentary regions is onlyavailable from 1 April 1999.

The proportion of the population who consult each year(annual patient rate) and the number of patients seen for osteoporosis in anyyear by a member of the practice team in Scotland can be estimated from Practice Team Information (PTI) data, which isdata received from a sample of Scottish practices. This data is currentlyavailable for the years 2003-04 to 2005-06 and is shown in the following table.

Osteoporosis – annual patient rates per 1,000 population andestimated number of patients consulting in Scotland; years ending 31 March 2004, 2005 and2006 by deprivationcategory.

Deprivation category (SIMD)	2003-04		2004-05		2005-06
	Annual patient rate per 1,000 population	Estimated number of patients	Annual patient rate per 1,000 population	Estimated number of patients	Annual patient rate per 1,000 population	Estimated number of patients
1 (least deprived)	4.0	4,250	3.0	3,200	3.7	3,950
2	3.6	3,750	3.4	3,600	2.6	2,850
3	3.3	3,450	3.0	3,150	2.4	2,600
4	4.0	4,300	3.2	3,400	2.7	2,850
5 (most deprived)	3.3	3,650	3.0	3,300	2.8	3,050
Scotland	3.6	19,300	3.1	16,600	2.8	15,250

Source: ISD.

Notes:

Estimated numbers of patients are rounded to the nearest 50.Total figures may not add up to the sum of the parts due to this rounding.

Due to the small numbers on which these estimates are based,care must be taken when examining these data as a trend.

the Scottish Indices of Multiple Deprivation (SIMD) are used here as a proxy forsocio-economic group.

Following asubstantial review of PTI data and subsequent revisions to the methodology forall PTI analyses, direct comparisons with figures produced prior to 27th March 2007 are not valid.  Furtherinformation can be found on the ISD website, at:

http://www.isdscotland.org/isd/4724.html.

Transport Scotland isleading work to provide firm proposals for the most cost-effective waysto improve reliability, bring down journey times and provide capacity for theexpected continuing growth in rail passenger numbers between Edinburgh andGlasgow. Electrification is one possible option for achieving this and thecosts, risks and benefits of such a project will be considered in the widercontext of the above service improvements. The results of this will be reportedin September and will be considered as part of the strategic transport projectsreview.

Transport Scotland isleading work to provide firm proposals for the most cost-effective waysto improve reliability, bring down journey times and provide capacity for theexpected continuing growth in rail passenger numbers between Edinburgh andGlasgow. Electrification is one possible option for achieving this and thecosts, risks and timescales of such a project will be considered in the widercontext of the above service improvements. The results of this will be reportedin September and will be considered as part of the strategic transport projectsreview.

Information on the incidenceof osteoporosis in Scotland is not available centrally, and the informationrequested is not available through Practice Team Information data.

Information for Scottish Parliamentary constituencies and for Scottish parliamentary regions is onlyavailable from 1 April 1999.

The information requested isnot available centrally.

Information for Scottish Parliamentary constituencies and for Scottish parliamentary regions is onlyavailable from 1 April 1999.

All NHS boards have accessto DEXA scanning. It should be noted however that patients in Forth Valleytravel to either Glasgow or Edinburgh. In Orkney and Shetland, patients travelto NHS Grampian and in the Western Isles, patients travel to Highland NHS.

Information on the incidenceof osteoporosis in Scotland is not available centrally. Information for Scottish Parliamentary constituencies and for Scottish parliamentary regions is onlyavailable from 1 April 1999.

The proportion of the population who consult each year(annual patient rate) and the number of patients seen for osteoporosis in anyyear by a member of the practice team in Scotland can be estimated from Practice Team Information (PTI) data, which is datareceived from a sample of Scottish practices. This data is currently availablefor the years 2003-04 to 2005-06.

Osteoporosis – annual patient rates per 1,000 population andestimated number of patients consulting in Scotland; years ending 31 March 2004, 2005 and2006 by gender and agegroup

 

Gender		2003-04		2004-05		2005-06
	Age group	Annual patient rate per 1,000 population	Estimated number of patients	Annual patient rate per 1,000 population	Estimated number of patients	Annual patient rate per 1,000 population	Estimated number of patients
Males	Under 50 years	0.1	250	0.1	200	0.1	100
	50 - 69	1.5	850	1.4	850	1.2	700
	70 - 79	4.2	700	4.6	750	3.4	550
	80 years & over	3.0	200	3.9	250	3.4	250
	All ages	0.8	2,000	0.8	2,100	0.6	1,600
Females	Under 50 years	0.6	1,000	0.4	650	0.4	650
	50 - 69	11.9	7,200	8.5	5,200	8.8	5,450
	70 - 79	27.1	5,800	25.0	5,350	23.3	5,000
	80 years & over	24.2	3,300	23.9	3,300	18.9	2,600
	All ages	6.4	17,350	5.4	14,500	5.0	13,700
Total	All ages	3.6	19,300	3.1	16,600	2.8	15,250

Source: ISD.

Notes:

Estimated numbers of patients are rounded to the nearest 50.Total figures may not add up to the sum of the parts due to this rounding.

Due to the small numbers on which these estimates are based,care must be taken when examining these data as a trend.

Following a substantial review of PTI data and subsequentrevisions to the methodology for all PTI analyses, direct comparisons withfigures produced prior to 27th March 2007are not valid.  Further information can be found on the ISD website, at:

http://www.isdscotland.org/isd/4724.html.

The number of skillseekerswho progressed to the modern apprenticeship programme is an operational matterfor Scottish Enterprise and Highlands and Islands Enterprise. This informationis not held centrally.

Not all of theinformation requested is held centrally.

(a)and (b):

Thelatest information available for Scotland is published in the Scottish Perinatal and InfantMortality and Morbidity Report (SPIMMR) 2005. This report is due to be updatedlater this year.

This2005 SPIMMR report is available via:

http://www.isdscotland.org/isd/servlet/FileBuffer?namedFile=mat_spimmer_2005.pdf&pContentDispositionType=inline.

Tables31 and 32a (pages 29-30) show the number and rates of singletons born in Scotland and detectedwith congenital anomalies (including figures for spina bifida) at birth or duringinfancy, 1995-2004. The figures included in these tables do not howeverinclude spina bifida pregnancies that were terminated.

Spina bifida is one of the conditions screened forduring pregnancy and if a termination is carried out for this reason it isrecorded on the Abortions Act data form. Table 32b (page 30) provides spinabifida rates per births and abortions. The total number of pregnancies used toderive the rates presented in table 32b are not included in the report.

Spina bifida pregnancies resulting in miscarriagewill not be included in these statistics.

(i):

Comparableinformation for the United Kingdom is not heldcentrally.

The NationalCongenital Anomaly System does however hold data for England and Wales. The estimated number of babies born in England and Wales during 2005 with spina bifida was 56. Thisequates to an incidence rate of 9 per 100,000 live births. This figure is notdirectly comparable with those presented above for Scotland as it does not include cases detected during infancy or terminations.

These figures arepublished on the Clinical and Health Outcomes Knowledge Base at:

http://www.nchod.nhs.uk/NCHOD/Compendium.nsf/f47084ec7cabf53b80256fcb0054ee1c/344eb1370e4ffd49652570d1001cb7fb!OpenDocument.

(ii) and (iii):

Comparableinformation for EU member states and the OECD nations is not held centrally. Weare not aware of a single source for this information.

The informationrequested is not held centrally.

However,background information relating to this request is available from a number ofsources.

Dundee University:

The UK CysticFibrosis Database is developed and maintained from Dundee University. Information about the database isavailable from:

http://www.cystic-fibrosis.org.uk/background.htm

Personnel at Dundee University are also driving the collation ofcomparable figures for EU member states. The latest available information ondata collated for the member states is available from:

www.eurocarecf.eu

Personnel at Dundee University have contributed to Chapter 2 of therecently published 3rd edition of Cystic Fibrosis (Authors: D Geddes, MHodson, A Bush).  This chapter presents an overview of estimated birthprevalence for Scotland, UKand a number of EU member states and OECD nations. In summary:

Around 20-25babies are born with Cystic fibrosis in Scotland each year, which equates to abirth prevalence rate of just under 1 in 2,000 live births.

For the UnitedKingdom, the number of babies born each year is approximately ten times theScotland figure at 200-250. The birth prevalence rate in the UK as a whole isestimated to be slightly lower than that observed in Scotland at around 1 in2,400 live births.

Cystic fibrosisis a genetic condition and birth prevalence rates vary between ethnic groupswithin countries. For example, in the United States the birth prevalenceamongst the white population is estimated to be approximately 1 in 3,400 livebirths, compared with a birth prevalence for the non-white population of around1 in 12,000 live births.

InformationServices Division of the NHS (ISD Scotland):

It is likely thatpatients with Cystic fibrosis will have contact with healthcare services in anumber of healthcare settings including, GP practices or as inpatients or daycases in an acute, general hospital.

Acute HospitalDischarge Information:

The incidence andnumber of patients discharged from acute, general hospitals in Scotland with a diagnosis of Cystic fibrosis is shown in the followingtable. 

Incidence,Incidence Rate and Number of Cases of Cystic Fibrosis in Patients Discharged fromAcute, General Hospitals in Scotland, Scottish Residents¹ - YearEnding 31st March 2006

Incidence2  with diagnosis3 of cystic fibrosis	71
Incidence rate per 100,000 population4	1.39
Cases5 with diagnosis of cystic fibrosis	484

Source:ISD Scotland linked SMR01 database.

Notes:

1.Excludesresidents out with Scotland, of no fixed abode or unknown.

2.Incidence isdefined as a patient’s first ever discharge with the specified diagnosisscreened backwards through the patient’s discharge history for 10 years (1996).

3. Up to six diagnoses (oneprincipal and up to five secondary) are recorded on SRM01.  All six diagnoseshave been used to identify cystic fibrosis employing the InternationalClassification of Diseases, 10th revision (ICD10) code E84.

4.Based on GRO(S) mid year population estimate for Scotland, 2005.

5. Patients discharged with diagnosisof cystic fibrosis (includes incident cases).

General PracticeInformation.

The incidence ofGP contacts with diagnosis of cystic fibrosis is not available centrallybecause numbers are too low to calculate meaningful, national estimates basedupon a sample of general practices from practice team information data.